Related Experiment Video
Updated: Apr 25, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancer
Roberto Iacovelli1, Matteo Santoni, Filippo de Braud
1Dipartimento di Oncologia Medica, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Abstract:
The genitourinary cancer symposium is one of the most important conferences focused on cancers of the prostate, penis, urethra, testes, bladder and kidney. This year the genitourinary symposium celebrated 10 years – its theme was 'integrating biology into patient-centric care'. The conference offered educational sessions and oral and poster abstract presentations; the general sessions throughout the meeting focused on prevention, screening, diagnosis, multidisciplinary treatment, translational research and current controversies in the field. Here, we report the main news reported at the symposium about the treatment of metastatic renal cell carcinoma and castration resistant prostate cancer.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers
Anatomy of the Genitourinary System II: Bladder and Urethra
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

